Modivcare CEO Dan Greenleaf leaves

  • Push-out Score determined
  • After less than three years in the position
  • Heath Sampson taking over temporarily
  • Search for a successor

(exechange) — Denver, Colorado, August 2, 2022 — Dan Greenleaf, chief executive of Modivcare, leaves. As announced by Modivcare Inc. in a news release and in a regulatory filing published on Tuesday, August 2, 2022, Daniel E. (Dan) Greenleaf has left his post as chief executive officer at the healthcare services company, after less than three years in the role, effective July 27, 2022.

Modivcare will undertake a search for a successor.

Dan Greenleaf’s duties as CEO will be taken over temporarily by L.Heath Sampson, currently Chief Financial Officer at Modivcare Inc., as Interim Chief Executive Officer.

“Now is the right time”

Dan Greenleaf’s departure from the CEO post is explained as follows. Chris Shackelton, Chairman of the Modivcare Board, said: “In an effort to better serve our stakeholders and position the Company as the leading supportive care provider in the nation, Modivcare has undergone a significant transformation over the last few years. The Board has determined that now is the right time to transition to our next phase of leadership.”

Precise information regarding Dan Greenleaf’s future plans was not immediately available.

“Is no longer serving”

Modivcare said: “Daniel E. Greenleaf is no longer serving as Chief Executive Officer and a member of the Company’s Board of Directors.”

Modivcare further said: “As of July 27, 2022, Daniel E. Greenleaf is no longer serving as President and Chief Executive Officer or as a member of the Board of Directors of Modivcare Inc. (the “Company”), although he will be compensated through August 1, 2022.”

Share price decline since August 2021

The announcement follows a decline in Modivcare Inc.’s share price of 41% since August 2021.

In the position of CEO since 2019

Dan Greenleaf became CEO of the Company in 2019.

Daniel E. Greenleaf served as the President and Chief Executive Officer of the Company.

Prior to joining the Company, from September 2016 through August 2019, Greenleaf served as President and Chief Executive Officer of BioScrip, Inc., the largest independent provider of infusion and home care management solutions, where he spearheaded the turnaround and successful merger of BioScrip with Option Care Health (Nasdaq: OPCH).

Prior to BioScrip, from December 2013 through September 2016, he served as Chairman and Chief Executive Officer of Home Solutions Infusion Services, a provider of home infusion and home nursing products and services, where he led the turnaround and eventual sale to BioScrip.

Prior to joining Home Solutions Infusion Services, from April 2008 through November 2012, Greenleaf was the President and Chief Executive Officer of Coram Specialty Services, where he was instrumental in growing Coram to become the top-performing home infusion company in the country prior to its sale to CVS.

Before joining Coram, Greenleaf served as President of U.S. Operations for Celltech Biopharmaceuticals.

Greenleaf holds a Bachelor of Arts in Economics from Denison University and a Master of Business Administration from the University of Miami.

Greenleaf is a military veteran, having served as a captain and navigator in the United States Air Force.

Push-out Score determined

The Push-out Score™ determined by exechange gauges the pressure surrounding Dan Greenleaf’s move on a scale of 0 to 10.

exechange reached out to Modivcare and offered the company the opportunity to comment on the score.

Read the full story in the exechange report 32.2022 ($).